ArticleTheranostics2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleTheranostics2021
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.